First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate

被引:4
作者
Vial, Pablo A. [1 ,7 ]
Gonzalez, Claudia [2 ]
Apablaza, Mauricio [3 ]
Vial, Cecilia [1 ]
Lavin, M. Estela [3 ]
Araos, Rafael [1 ]
Rubilar, Paola [2 ]
Icaza, Gloria [5 ]
Florea, Andrei [1 ]
Perez, Claudia [4 ]
Concha, Paula [4 ]
Bastias, Diego [4 ]
Errazuriz, Maria Paz [4 ]
Perez, Ruth [1 ]
Guzman, Francisco
Olea, Andrea [2 ]
Guzman, Eugenio [3 ]
Correa, Juan [6 ]
Munita, Jose Manuel [1 ]
Aguilera, Ximena [2 ]
机构
[1] Univ Desarrollo, Fac Med Clin Alemana, Inst Ciencias Innovac Med, Ave Plaza 680, Santiago 7610658, Chile
[2] Univ Desarrollo, Ctr Epidemiol & Polit Salud, Fac Med Clin Alemana, Ave Plaza 680, Santiago 7610658, Chile
[3] Univ Desarrollo, Fac Gobierno, Ave Plaza 680, Santiago 7610658, Chile
[4] Univ Desarrollo, Escuela Enfermeria, Fac Med Clin Alemana, Ave Plaza 680, Santiago 7610658, Chile
[5] Univ Talca, Inst Matemat & Fis, Calle Norte 685, Talca 3465548, Chile
[6] Univ Las Amer, Ctr Prod Espacio, Ave Manuel Montt 948, Santiago 7500975, Chile
[7] Ave Plaza 680, Santiago 7610658, Chile
关键词
Chile; Seroprevalence; COVID-19; Pandemic; SARS-COV-2; Infection fatality rate; IgG; IgM; First wave; COVID-19;
D O I
10.1016/j.epidem.2022.100606
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The first wave of SARS-CoV-2 infection in Chile occurred during the cold season reaching a peak by the end of June 2020, with 80 % of the cases concentrated in its capital, Santiago. The main objective of this study was to estimate the attack rate during this first wave of SARS-CoV-2 in a large, densely populated city with more than seven million inhabitants. Since the number of confirmed cases provides biased information due to individuals' potential self-selection, mostly related to asymptomatic patients and testing access, we measured antibodies against SARS-CoV-2 to assess infection prevalence during the first wave in the city, as well as estimate asymptomatic cases, and infection fatality ratio. To our knowledge this is one of the few population-based crosssectional serosurvey during the first wave in a highly affected emerging country. The challenges of pandemic response in urban settings in a capital city like Santiago, with heterogeneous subpopulations and high mobility through public transportation, highlight the necessity of more accurate information regarding the first waves of new emerging diseases.Methods: From April 24 to June 21, 2020, 1326 individuals were sampled from a long-standing panel of household representatives of Santiago. Immunochromatographic assays were used to detect IgM and IgG antibody isotypes.Results: Seroprevalence reached 6.79 % (95 %CI 5.58 %-8.26 %) in the first 107 days of the pandemic, without significant differences among sex and age groups; this figure indicates an attack rate 2.8 times higher than the one calculated with registered cases. It also changes the fatality rate estimates, from a 2.33 % case fatality rate reported by MOH to an estimated crude 1.00 % (CI95 % 0.97-1.03) infection fatality rate (adjusted for test performance 1.66 % [CI95 % 1.61-1.71]). Most seropositive were symptomatic (81,1 %).Conclusions: Despite the high number of cases registered, mortality rates, and the stress produced over the health system, the vast majority of the people remained susceptible to potential new epidemic waves. We contribute to the understanding of the initial spread of emerging epidemic threats. Consequently, our results provide better information to design early strategies that counterattack new health challenges in urban contexts.
引用
收藏
页数:7
相关论文
共 25 条
  • [21] Real-time seroprevalence and exposure levels of emerging pathogens in infection-naive host populations
    Pinotti, Francesco
    Obolski, Uri
    Wikramaratna, Paul
    Giovanetti, Marta
    Paton, Robert
    Klenerman, Paul
    Thompson, Craig
    Gupta, Sunetra
    Lourenco, Jose
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
    Pollan, Marina
    Perez-Gomez, Beatriz
    Pastor-Barriuso, Roberto
    Oteo, Jesus
    Hernan, Miguel A.
    Perez-Olmeda, Mayte
    Sanmartin, Jose L.
    Fernandez-Garcia, Aurora
    Cruz, Israel
    Fernandez de Larrea, Nerea
    Molina, Marta
    Rodriguez-Cabrera, Francisco
    Martin, Mariano
    Merino-Amador, Paloma
    Paniagua, Jose Leon
    Munoz-Montalvo, Juan F.
    Blanco, Faustino
    Yotti, Raquel
    [J]. LANCET, 2020, 396 (10250) : 535 - 544
  • [23] SARS-CoV-2 prevalence associated to low socioeconomic status and overcrowding in an LMIC megacity: A population-based seroepidemiological survey in Lima, Peru
    Reyes-Vega, Mary F.
    Gabriela Soto-Cabezas, M.
    Cardenas, Fany
    Martel, Kevin S.
    Valle, Andree
    Valverde, Juan
    Vidal-Anzardo, Margot
    Elena Falcon, Maria
    Munayco, Cesar, V
    [J]. ECLINICALMEDICINE, 2021, 34
  • [24] SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
    Rostami, Ali
    Sepidarkish, Mahdi
    Leeflang, Mariska M. G.
    Riahi, Seyed Mohammad
    Shiadeh, Malihe Nourollahpour
    Esfandyari, Sahar
    Mokdad, Ali H.
    Hotez, Peter J.
    Gasser, Robin B.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (03) : 331 - 340
  • [25] Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
    Stringhini, Silvia
    Wisniak, Ania
    Piumatti, Giovanni
    Azman, Andrew S.
    Lauer, Stephen A.
    Baysson, Helene
    De Ridder, David
    Petrovic, Dusan
    Schrempft, Stephanie
    Marcus, Kailing
    Yerly, Sabine
    Vernez, Isabelle Arm
    Keiser, Olivia
    Hurst, Samia
    Posfay-Barbe, Klara M.
    Trono, Didier
    Pittet, Didier
    Getaz, Laurent
    Chappuis, Francois
    Eckerle, Isabella
    Vuilleumier, Nicolas
    Meyer, Benjamin
    Flahault, Antoine
    Kaiser, Laurent
    Guessous, Idris
    [J]. LANCET, 2020, 396 (10247) : 313 - 319